Back to search

Botulinum Toxin Type A for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double-Blind, Placebo-Controlled Trial

Data up to Jan 2025

Published2005
Citations178
References35

Total Citations Per Year

Abstract

References (35)

Nonparametric Statistics for the Behavioral Sciences.

1957 • 8,423 citations

Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover Study

1988 • 3,495 citations

Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) [RETIRED]

2000 • 1,355 citations

Epidemiology of Chronic Daily Headache in the General Population

1999 • 724 citations

Subcutaneous administration of botulinum toxin A reduces formalin-induced pain

2003 • 652 citations

Topiramate for Migraine Prevention<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2004 • 631 citations

Classification of daily and near-daily headaches

1996 • 619 citations

Periaqueductal Gray Matter Dysfunction in Migraine: Cause or the Burden of Illness?

2001 • 613 citations

Botulinum Toxin Type A as a Migraine Preventive Treatment

2000 • 540 citations

Regulation of Calcitonin Gene‐Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy

2004 • 528 citations

Topiramate in Migraine Prevention

2004 • 523 citations

Transformed or Evolutive Migraine

1987 • 400 citations

Evidence for Antinociceptive Activity of Botulinum Toxin Type A in Pain Management

2003 • 391 citations

Features of medication overuse headache following overuse of different acute headache drugs

2002 • 378 citations

Chronic daily headache

2000 • 306 citations

Chronic daily headache in Chinese elderly

2000 • 276 citations

Botulinum Toxin Type A (BOTOX®) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial

2005 • 270 citations

Migraine: Preventive Treatment

2002 • 255 citations

Synaptic Transmission: Inhibition of Neurotransmitter Release by Botulinum Toxins

2003 • 233 citations

Topiramate in the Treatment of Chronic Migraine

2003 • 161 citations

Chronic Daily Headache: Identification of Factors Associated With Induction and Transformation

2002 • 158 citations

Epidemiology of chronic daily headache

2001 • 153 citations

Gabapentin in the prophylaxis of chronic daily headache

2003 • 142 citations

Chronic Daily Headache Prophylaxis With Tizanidine: A Double‐Blind, Placebo‐Controlled, Multicenter Outcome Study

2002 • 136 citations

Risk factors for chronic daily headache

2002 • 121 citations

Migraine Preventive Medication Reduces Resource Utilization

2003 • 113 citations

Chronic refractory headache.

1993 • 105 citations

Botulinum Toxin Type A as an Effective Prophylactic Treatment in Primary Headache Disorders

2003 • 95 citations

Chronic daily headache: nosology and pathophysiology

2002 • 86 citations

The International Headache Society (IHS) Headache Classification as Applied to a Headache Clinic Population

1994 • 85 citations

Procedures for Administering Botulinum Toxin Type A for Migraine and Tension‐type Headache

2003 • 79 citations

Prophylactic Pharmacological Treatment of Chronic Daily Headache

2000 • 73 citations

Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study

2003 • 66 citations

Placebo Effect and Clinical Trials in Migraine Therapy

1987 • 50 citations

Ethical Aspects of Placebo in Migraine Research

2003 • 24 citations

Cited By (0)

Loading...